The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment

Background. Chinese herbal medicine (CHM) has been used for thousands of year in Eastern countries. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment is the standard treatment in stage IV pulmonary adenocarcinoma patients who had tumor EGFR mutations. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Hsiu-Ying, Tseng, Yen-Han, Liao, Chia-Miao, Chen, Sung-Yi, Wu, Ta-Peng, Lee, Yu-Chin, Chen, Yuh-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736065/
https://www.ncbi.nlm.nih.gov/pubmed/27151582
http://dx.doi.org/10.1177/1534735416645181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736065/
https://www.ncbi.nlm.nih.gov/pubmed/27151582
http://dx.doi.org/10.1177/1534735416645181

Ejemplares similares